March 2020
Patient Care

Mayo specialists consider three key points when determining optimal treatments for patients with Peyronie's disease: baseline erectile function, duration of symptoms and level of invasiveness the patient will consider.
Research

Research supports the use of docetaxel before enzalutamide or abiraterone as the primary first line therapy for metastatic castration-resistant prostate cancer.

A retrospective review of patients who received percutaneous image-guided core-needle biopsy for diagnosis of upper tract urothelial carcinoma supports that the process is safe and well tolerated by those patients.
Education

Feb. 11-14, 2021, in Paradise Island, Commonwealth of The Bahamas
Review the diagnoses and management of urologic conditions influenced by recent medical, surgical, and technological advances. Explore novel therapies for prostate cancer, kidney cancer, bladder cancer, benign prostatic hyperplasia and incontinence.
Consults and Referrals

866-629-6362 (toll-free)

800-634-1417 (toll-free)

800-533-1564 (toll-free)
Connect With Us
Mayo Clinic

13400 E. Shea Blvd.
Scottsdale, AZ 85259

4500 San Pablo Road
Jacksonville, FL 32224

200 First St. SW
Rochester, MN 55905